News & Press: Breaking News

US FDA Announces Increased Efforts to Ensure Proper Oversight of Stem Cell Therapies

Monday, August 28, 2017  
Share |

 

August 28 US FDA Commissioner Scott Gottlieb, M.D., issues statement on the FDA's new policy steps and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine. Read the News Release

August 28 US FDA warns US Stem Cell Clinic of significant deviations. Read the News Release

August 24 US FDA issues Warning Letter to US Stem Cell Clinic, LLC Read the Warning Letter


© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.